48
© Cengage Learning 2016 © Cengage Learning 2016 Psychopharmacology Chapter Four

Chapter Four Psychopharmacology

Embed Size (px)

DESCRIPTION

Neurotransmitters, Neuromodulators, and Neurohormones Participate in directed synapses by acting on neurons in their own immediate vicinity Neuromodulators and neurohormones Participate in nondirected synapses by acting on more distant neurons Neuromodulators communicate with target diffuse away from the point of release Neurohormones travel in the blood supply to reach their final targets

Citation preview

Page 1: Chapter Four Psychopharmacology

© Cengage Learning 2016 © Cengage Learning 2016

Psychopharmacology

Chapter Four

Page 2: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Neurotransmitters – Participate in directed synapses by acting on

neurons in their own immediate vicinity

• Neuromodulators and neurohormones– Participate in nondirected synapses by acting

on more distant neurons– Neuromodulators communicate with target

diffuse away from the point of release– Neurohormones travel in the blood supply to

reach their final targets

Neurotransmitters, Neuromodulators, and Neurohormones

Page 3: Chapter Four Psychopharmacology

© Cengage Learning 2016

Neuromodulators and Neurohormones

Page 4: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Substances released by one cell that produce a reaction in a target cell

• The substance: – Must be present within a presynaptic cell.– Is released in response to presynaptic

depolarization– Interacts with specific receptors on a

postsynaptic cell

Identifying Neurochemicals

Page 5: Chapter Four Psychopharmacology

© Cengage Learning 2016

Types of Neurochemicals

Page 6: Chapter Four Psychopharmacology

© Cengage Learning 2016

Features of Small-Molecules and Neuropeptides

Page 7: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Produced in cholinergic neurons • Two receptor types:

– Nicotinic receptors– Muscarinic receptors

Small-Molecule Neurochemicals: Acetylcholine

Page 8: Chapter Four Psychopharmacology

© Cengage Learning 2016

The Distribution of Cholinergic Systems in the Brain

Page 9: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Catecholamines– Dopamine, norepinephrine, epinephrine– Synthesized from tyrosine

• Indoleamines– Serotonin, melatonin– Serotonin is synthesized from tryptophan

Small-Molecule Neurochemicals: Monoamines

Page 10: Chapter Four Psychopharmacology

© Cengage Learning 2016

Catecholamines Share a CommonSynthesis Pathway

Page 11: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Dopaminergic neurons in the midbrain form connections with other neurons

• Dopamine activity is associated with motivated behavior and reward processing

Dopaminergic Systems in the Brain

Page 12: Chapter Four Psychopharmacology

© Cengage Learning 2016

Dopaminergic Systems in the Brain (cont’d.)

Page 13: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Norepinephrine– Noradrenergic neurons– Increases arousal and vigilance– Primary neurotransmitter in the sympathetic

nervous system

• Epinephrine– Adrenergic neurons– Regulation of eating, blood pressure

Noradrenergic Systems in the Brain

Page 14: Chapter Four Psychopharmacology

© Cengage Learning 2016

Noradrenergic Systems in the Brain (cont’d.)

Page 15: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Synthesized from tryptophan• Regulates mood, sleep, and appetite

Indoleamines: Serotonin

Page 16: Chapter Four Psychopharmacology

© Cengage Learning 2016

Serotonergic Pathways in the Brain

Page 17: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Synthesized from histidine• Associated with wakefulness

Histamine

Page 18: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Major excitatory neurotransmitter in the CNS

• Subtypes of glutamate receptors: NMDA, AMPA, and kainate

Amino Acid Messengers: Glutamate

Page 19: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Major inhibitory neurochemical in the CNS• Synthesized from glutamate• GABAA and GABAB receptors

– GABAA receptors interact with psychoactive drugs

Amino Acid Messengers: GABA

Page 20: Chapter Four Psychopharmacology

© Cengage Learning 2016

The GABAA Receptor Interacts with Several Drugs

Page 21: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Major inhibitory neurochemical in spinal cord interneurons

• Excitatory function with glutamate at NMDA receptors

• Synthesized from serine

Amino Acid Messengers: Glycine

Page 22: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Act in the CNS and in connections between autonomic neurons and the vas deferens, bladder, heart, and gut– ATP is associated with pain perception and

sleep-waking cycles– Adenosine inhibits the release of many

neurochemicals

ATP and Adenosine

Page 23: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Substance P (pain perception)• Endorphins act on same receptors as

opioids and heroin• Insulin and cholecystokinin function in

digestion and as neuromodulators and neurohormones

• Oxytocin and vasopressin act as neuromodulators and neurohormones

Neuropeptides

Page 24: Chapter Four Psychopharmacology

© Cengage Learning 2016

Distribution of Endorphin Receptors in the Human Brain

Page 25: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Diffuse through membranes and interact with intracellular receptors

• Transmits information from the postsynaptic to the presynaptic neurons

• Nitric oxide (NO)– Neural communication, maintenance of blood

pressure, erection (target of Viagra)

Gasotransmitters

Page 26: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Agonists enhance the activity of a neurotransmitter

• Antagonists reduce the activity of a neurotransmitter

Drug Actions at the Synapse

Page 27: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Neurochemical production– Manipulating the synthesis of a

neurotransmitter may affect the amount available for release

• Neurochemical storage– Interfering with the storage of a

neurotransmitters in vesicles within a neuron

• Neurochemical release– Can be modified in response to the arrival of

an action potential by drugs

Mechanisms of Drug Actions at the Synapse

Page 28: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Mimic the action of a neurotransmitter at the site

• Block the synaptic activity by occupying a binding site

• Influence the activity of the receptor

Mechanisms of Drug Actions at the Synapse: Receptor Effects

Page 29: Chapter Four Psychopharmacology

© Cengage Learning 2016

Drug Interactions at the Cholinergic Synapse

Page 30: Chapter Four Psychopharmacology

© Cengage Learning 2016

Drug Interactions at the Dopaminergic Synapse

Page 31: Chapter Four Psychopharmacology

© Cengage Learning 2016

Drug Interactions at the Serotonergic Synapse

Page 32: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Reuptake effects– Cocaine, amphetamine, and Ritalin inhibit

dopamine reuptake– SSRIs (e.g., Prozac) inhibit serotonin

reuptake

• Enzymatic degradation– Organophosphates interfere with AChE

• Deactivation of neurotransmitters

Reuptake Effects and Enzymatic Degradation

Page 33: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Administration of drugs– Method of administration leads to different

effects on nervous system; blood-brain barrier

• Individual differences– Drug effects influenced by body weight,

gender, and genetics

• Placebo effects– User expectations influence drug effects– Double-blind experiment

Basic Principles of Drug Effects

Page 34: Chapter Four Psychopharmacology

© Cengage Learning 2016

Concentration of a Drug in the Blood Supply Depends on the Method of Administration

Page 35: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Tolerance – Lessened effects as a result of repeated

administration

• Withdrawal– Occurs when substance use is discontinued;

opposite of the effects caused by the discontinued drug

• Addiction– Compulsive need to use the drug repeatedly

despite harm to the user

Tolerance, Withdrawal, and Addiction

Page 36: Chapter Four Psychopharmacology

© Cengage Learning 2016

Vaccinations Against Drugs of Abuse

Page 37: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Increase alertness and mobility– Caffeine – adenosine antagonist– Nicotine – nicotinic cholinergic receptor

agonist – Cocaine – dopamine reuptake inhibitor– Amphetamine – stimulates release and

inhibits reuptake of dopamine/norepinephrine– Ecstasy (MDMA) – stimulates release of

serotonin and oxytocin; toxic to serotonergic neurons

Effects of Psychoactive Drugs: Stimulants

Page 38: Chapter Four Psychopharmacology

© Cengage Learning 2016

Caffeine Content of Common Products

Page 39: Chapter Four Psychopharmacology

© Cengage Learning 2016

Caffeine Content of Common Products (cont’d.)

Page 40: Chapter Four Psychopharmacology

© Cengage Learning 2016

Health Consequences of Methamphetamine Abuse

Page 41: Chapter Four Psychopharmacology

© Cengage Learning 2016

Historical Use of Cocaine

Page 42: Chapter Four Psychopharmacology

© Cengage Learning 2016

Ecstasy Damages Serotonergic Neurons

Page 43: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Interact with endorphin receptors– Pain relief, relaxation, sense of euphoria

• Opiates– Derived from sap of opium poppy– Morphine, codeine – Heroin

• Synthetic opiate• Derived from morphine

Opioids

Page 44: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Active ingredient THC is an endogenous cannabinoid receptor agonist

• Cannabinoid receptors are in the hippocampus and prefrontal cortex

• Effects: mild euphoria, perceptual distortion, hallucination, and depression

Marijuana (Cannabis)

Page 45: Chapter Four Psychopharmacology

© Cengage Learning 2016

Cannabis and the Risk of Psychosis

Page 46: Chapter Four Psychopharmacology

© Cengage Learning 2016

• Serotonergic agonist• No known medicinal value• Hallucinogens• Use results in tolerance, but not addiction

or withdrawal• Flashbacks with extended use

LSD

Page 47: Chapter Four Psychopharmacology

© Cengage Learning 2016

• GABAA receptor agonist • Stimulates dopaminergic reward pathways• Rapid tolerance• Damaging effects on health

Alcohol

Page 48: Chapter Four Psychopharmacology

© Cengage Learning 2016

Alcohol and Mortality